Cardiac Alterations in Patients with Familial Lipodystrophy

Area of Science:

• Cardiology
• Genetics
• Metabolic Diseases

Background:

• Familial lipodystrophy is a rare genetic disorder characterized by metabolic changes and abnormal body fat distribution.
• A significant, yet understudied, complication is the development of cardiomyopathy.
• Hypertrophic cardiomyopathy is the most frequently reported cardiac manifestation in the literature.

Purpose of the Study:

• To review the clinical and cardiovascular imaging aspects of cardiomyopathy in familial lipodystrophy.
• To synthesize the latest scientific evidence on this rare metabolic disease-associated cardiomyopathy.

Main Methods:

• Bibliographic review of scientific literature.
• Focus on recent and advanced imaging techniques, particularly cardiac magnetic resonance.

Main Results:

• Frequent association between congenital lipodystrophy and ventricular hypertrophy is noted.
• Pathophysiological mechanisms underlying this cardiomyopathy remain largely unclear.
• Emerging data on cardiac morphology are being provided by advanced imaging methods.

Conclusions:

• Cardiomyopathy is a significant concern in familial lipodystrophy.
• Further research, especially utilizing advanced cardiac imaging, is needed to elucidate the pathophysiology and improve patient management.